Greenwood Capital Associates’s Steris STE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,437
| Closed | -$585K | – | 274 |
|
|
2025
Q2 | $585K | Sell |
2,437
-717
| -23% | -$167K | 0.07% | 174 |
|
|
2025
Q1 | $715K | Buy |
3,154
+16
| +0.5% | +$3.52K | 0.1% | 153 |
|
|
2024
Q4 | $645K | Sell |
3,138
-151
| -5% | -$33.1K | 0.08% | 166 |
|
|
2024
Q3 | $798K | Sell |
3,289
-75
| -2% | -$17.5K | 0.1% | 154 |
|
|
2024
Q2 | $739K | Sell |
3,364
-218
| -6% | -$47.4K | 0.1% | 162 |
|
|
2024
Q1 | $805K | Sell |
3,582
-67
| -2% | -$15.1K | 0.11% | 155 |
|
|
2023
Q4 | $802K | Sell |
3,649
-273
| -7% | -$57.7K | 0.1% | 149 |
|
|
2023
Q3 | $861K | Sell |
3,922
-70
| -2% | -$15.8K | 0.13% | 149 |
|
|
2023
Q2 | $898K | Sell |
3,992
-150
| -4% | -$30K | 0.13% | 142 |
|
|
2023
Q1 | $792K | Buy |
4,142
+49
| +1% | +$9.47K | 0.11% | 151 |
|
|
2022
Q4 | $756K | Sell |
4,093
-585
| -13% | -$103K | 0.12% | 139 |
|
|
2022
Q3 | $778K | Sell |
4,678
-1,638
| -26% | -$333K | 0.13% | 136 |
|
|
2022
Q2 | $1.3M | Buy |
6,316
+6,281
| +17,946% | +$1.42M | 0.21% | 88 |
|
|
2022
Q1 | $8K | Sell |
35
-7,457
| -100% | -$1.73M | ﹤0.01% | 200 |
|
|
2021
Q4 | $1.82M | Sell |
7,492
-984
| -12% | -$225K | 0.26% | 74 |
|
|
2021
Q3 | $1.73M | Sell |
8,476
-86
| -1% | -$18.4K | 0.27% | 75 |
|
|
2021
Q2 | $1.77M | Buy |
8,562
+2,909
| +51% | +$586K | 0.27% | 73 |
|
|
2021
Q1 | $1.08M | Sell |
5,653
-507
| -8% | -$94.1K | 0.17% | 100 |
|
|
2020
Q4 | $1.17M | Buy |
6,160
+1,055
| +21% | +$197K | 0.2% | 91 |
|
|
2020
Q3 | $900K | Buy |
5,105
+2,392
| +88% | +$382K | 0.17% | 86 |
|
|
2020
Q2 | $416K | Buy |
2,713
+112
| +4% | +$17.1K | 0.09% | 112 |
|
|
2020
Q1 | $364K | Buy |
+2,601
| New | +$389K | 0.11% | 92 |
|
|
2019
Q2 | – | Sell |
-5,785
| Closed | -$741K | – | 199 |
|
|
2019
Q1 | $741K | Buy |
5,785
+63
| +1% | +$7.42K | 0.19% | 76 |
|
|
2018
Q4 | $611K | Buy |
5,722
+1,531
| +37% | +$171K | 0.16% | 85 |
|
|
2018
Q3 | $479K | Buy |
4,191
+4
| +0.1% | +$452 | 0.1% | 110 |
|
|
2018
Q2 | $440K | Buy |
4,187
+941
| +29% | +$94.7K | 0.1% | 109 |
|
|
2018
Q1 | $303K | Sell |
3,246
-3,959
| -55% | -$360K | 0.07% | 137 |
|
|
2017
Q4 | $630K | Sell |
7,205
-443
| -6% | -$39.5K | 0.15% | 102 |
|
|
2017
Q3 | $676K | Sell |
7,648
-264
| -3% | -$22.4K | 0.17% | 94 |
|
|
2017
Q2 | $645K | Sell |
7,912
-476
| -6% | -$36.2K | 0.17% | 94 |
|
|
2017
Q1 | $583K | Sell |
8,388
-5,463
| -39% | -$378K | 0.15% | 102 |
|
|
2016
Q4 | $933K | Sell |
13,851
-421
| -3% | -$28.6K | 0.26% | 89 |
|
|
2016
Q3 | $1.04M | Sell |
14,272
-2,761
| -16% | -$195K | 0.32% | 82 |
|
|
2016
Q2 | $1.17M | Buy |
17,033
+7,712
| +83% | +$540K | 0.36% | 80 |
|
|
2016
Q1 | $662K | Buy |
9,321
+265
| +3% | +$17.9K | 0.21% | 89 |
|
|
2015
Q4 | $682K | Buy |
9,056
+2,270
| +33% | +$164K | 0.22% | 82 |
|
|
2015
Q3 | $441K | Buy |
6,786
+220
| +3% | +$14.5K | 0.16% | 89 |
|
|
2015
Q2 | $423K | Buy |
6,566
+894
| +16% | +$60.3K | 0.13% | 96 |
|
|
2015
Q1 | $398K | Buy |
5,672
+533
| +10% | +$35.2K | 0.11% | 97 |
|
|
2014
Q4 | $333K | Buy |
+5,139
| New | +$317K | 0.1% | 101 |
|
Other funds holding STE
GIM
OAG
Greenwood Capital Associates's STE Position: Q3 2025 in Review
Greenwood Capital Associates sold out of Steris (STE) in Q3 2025, closing a stake of 2,437 shares — an estimated $585K sold.
Greenwood Capital Associates first reported a position in STE in Q4 2014 and held it in 40 quarters. The position peaked at $1.82M in Q4 2021. 842 funds tracked by Wall St. Rank hold STE as of Q3 2025.
- Greenwood Capital Associates reported no remaining Steris position as of Q3 2025 after selling out during the quarter.
- Greenwood Capital Associates sold 2,437 Steris shares in Q3 2025, an estimated $585K.
- Greenwood Capital Associates first reported a position in Steris in Q4 2014 and held it in 40 quarters.
- Greenwood Capital Associates's Steris position peaked at $1.82M in Q4 2021.
- 842 funds tracked by Wall St. Rank held Steris as of Q3 2025.
Based on Greenwood Capital Associates's 13F filing for Q3 2025, filed 16 Oct 2025.